A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

Part of paid clinical trials in Durate, California.

Sponsor
City of Hope Medical Center
Study ID
NCT05751434
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Exercise Therapy — BEHAVIORAL
    The intervention will consist of exercise therapy, individualized, walking delivered following a non-linear (i.e., exercise dose is continually altered and progressed in conjunction with appropriate rest/recovery sessions across the entire intervention period) dosing schedule, up to 5 individual treatment sessions/week to achieve a cumulative total duration of 225 to 300 mins/wk until the participant's next standard of care prostate biopsy (about 6-12 months).

Study Details

To determine the effects of exercise therapy on molecular, radiologic, and pathologic nimbosus hallmarks versus usual care control in men on Active Surveillance for localized prostate cancer.

Key Dates

First listed
Mar 2, 2023
Start date
Feb 10, 2023
Status verified
Jul 2026
Primary completion
Mar 1, 2028
Completion
Jun 1, 2028

Study Design

Enrollment
102 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Participants Assigned to Exercise Therapy
    Participants with histologically confirmed localized prostate cancer undergoing active surveillance
  • No Intervention: Participants Assigned to Usual Care
    Participants with histologically confirmed localized prostate cancer undergoing active surveillance

Primary Outcome Measure

Change in molecular, radiologic, and pathologic nimbosus hallmarks from baseline to follow-up [ Time Frame: 6-12 months ]

Central Contacts

Locations (10)

FacilityCityStateZIPSite coordinators
City of Hope Medical CenterDurateCalifornia91010
Lee Jones
[email protected]
6262184673
University of California, Los Angeles (Data and Specimen Analysis Only)Los AngelesCalifornia90095-1781
Paul Boutros, PhD
310-794-7160
Jaron Arbet, PhD
Hartford Healthcare Alliance (Data collection only)HartfordConnecticut06102
Andrew Salner, MD
(860) 972-2803
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking RidgeNew Jersey07920
Jessica Scott, PhD
646-888-8093
Memorial Sloan Kettering Monmouth (Limited protocol activities)MiddletownNew Jersey07748
Jessica Scott, PhD
646-888-8093
Memorial Sloan Kettering Bergen (Limited protocol activities)MontvaleNew Jersey07645
Jessica Scott, PhD
646-888-8093
Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities)CommackNew York11725
Jessica Scott, PhD
646-888-8093
Memorial Sloan Kettering Westchester (Limited protocol activities)HarrisonNew York10604
Jessica Scott, PhD
646-888-8093
Memorial Sloan Kettering Cancer Center (All Protocol Activities)New YorkNew York10065
Jessica Scott, PhD
646-888-8093
Memorial Sloan Kettering Nassau (Limited protocol activites)Rockville CentreNew York11553
Jessica Scott, PhD
646-888-8093

Find similar trials in Durate, CA

Nationwide
Prostate cancer trialsOncology trialsProstate oncology trialsMen's health trialsUrology trials
By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
City of Hope Medical Center· Durate, CAUniversity of California, Los Angeles (Data and Specimen Analysis Only)· Los Angeles, CAHartford Healthcare Alliance (Data collection only)· Hartford, CTMemorial Sloan Kettering Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited protocol activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited protocol activities)· Montvale, NJ

Related Studies